Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year


Total Raised


About iONGen

Developer of products for integrative cancer management. The company develops products that will offer tools for the managing of all aspects of cancer, from prophylaxis to follow-up through accurate diagnosis, localization and therapy. The company's product development is based on a proprietary tumor marker, EAG, a protein that shows specificity for tumor cells and that is also an extraordinary therapeutic target.

iONGen Headquarter Location

Rudolf-Wissell-Strasse 28

Goettingen, 37079,


49 5515213980

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.